The Efficacy of premedication of PassifloraIncarnata Linnaeus in reducing patients' anxiety

Evaluation The Efficacy of premedication of PassifloraIncarnata Linnaeus Compared to placebo on patients' anxiety

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200127046277N1

Enrollment

Registered

2020-03-26

Start date

2019-09-23

Completion date

Unknown

Last updated

2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety. Anxiety disorder due to known physiological condition

Interventions

Intervention 1: Intervention group 1: Use of Passiflora-This group will receive the oral premedication of the Passiflora extract. These people will consume 25 drops of the Passiflora extract at the ni

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients whose anxiety score is more than 9 based on the Corah questionnaire need root canal therapy

Exclusion criteria

Exclusion criteria: Psychotropic drugs usage Liver and blood problems Pregnancy Gastrointestinal diseases

Design outcomes

Primary

Measure	Time frame
Anxiety score. Timepoint: The night before treatment and 90 minutes before treatment. Method of measurement: questionnaire Corah’s Dental Anxiety Scale (DAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Ghazalgoo

Esfahan University of Medical Sciences

alighazalgoo@yahoo.com+98 31 3792 5547

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026